Atlas Trials

Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation

Clinical trial NCT03680092 · COMPLETED

Trial details

NCT number
NCT03680092
Sponsor
Dimitrios Tzachanis, MD PhD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
GVHDHematologic Neoplasms
Start date
2019-11-26
Primary completion
2023-06-15
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.